$ARCC

ARES CAPITAL CORP (ARCC): Submission of Matters to a Vote of Security Holders

ARES CAPITAL CORP (ARCC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders . Special Meeting of Stockholders On August 13, 2026, Ares Capital Corporation (the “Company”) held its special meeting of stockholders (the “Special Meeting”). The issued and outstanding shares of stock of the Company

Original reporting
Published Aug 14, 2026, 8:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ARCC
Neutral
medium confidence
Mentioned
$ARCC
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARCCNeutralLow
01

Why it matters

Stockholders approved a board-authorized ability to sell or issue common stock at a price below then-current NAV per share, subject to limitations including a 25% of outstanding shares cap, effective for issuances during a 12-month period expiring Aug 13, 2027.

02

Market read

This provides financing flexibility for potential future equity issuance below NAV, but the filing itself does not indicate an immediate capital raise.

03

What to watch

Traders should focus on whether ARCC later announces an actual issuance, the size, pricing versus NAV, and any concurrent balance-sheet or credit-cycle developments.

Relevance 6/10Novelty 5/10Timing: filed Aug 14, 2026, covering an Aug 13 special meeting vote

Background

ARCC filed an 8-K for Item 5.07 reporting results of a special stockholder meeting held Aug 13, 2026.

Company-level read

Ticker impact

$ARCCNeutralMedium confidence
Context

ARCC disclosed stockholder approval of a 12-month authorization to issue common shares below NAV, capped at 25% of outstanding shares.

Expected impact

Near-term impact likely limited unless ARCC signals imminent use of the authorization; watch for subsequent issuance announcements.

Evidence & confidence

This is a corporate governance and financing flexibility update. The filing does not announce an issuance, but it removes a key procedural constraint for future capital raises.

Market effects

BDC peers may face similar scrutiny around equity issuance below NAV, but this filing is company-specific.

None indicated.

None indicated.

Counterpoint

Approval may be largely routine, and ARCC may not use the authorization if market conditions or funding needs do not justify dilution.

Key entities

  • Ares Capital Corporation

    BDC that received stockholder approval for a below-NAV equity issuance authorization.

  • Common stock

    ARCC common shares subject to the approved issuance authorization.

Related articles

$ARCCMed

Ares Leads $2.2 Billion Healthcare Loan

Ares Management Corp. is leading a $2.2 billion loan to MedImpact Holding Inc. to finance its acquisition of Medical Card System, Inc. The second-lien loan may pay at least 8% over the baseline rate. Ares manages $671 billion in assets and recently reported $708 billion in non-accruing loans. MedImpact serves 20 million customers and processes $40 billion in pharmacy transactions annually.

$ARCCMed

Ares Capital Q2 Earnings Call Highlights

Management expects industry credit conditions to continue normalizing toward longer-term averages, though it said performance differences among managers have widened. Schnabel said Ares Capital added four investments to non-accrual during the quarter, but the companies were in unrelated businesses and did not indicate a sector-specific trend.

$ARCCMed

ARES CAPITAL CORP (ARCC): Results of Operations and Financial Condition

ARES CAPITAL CORP (ARCC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ARES CAPITAL CORPORATION ANNOUNCES JUNE 30, 2026 FINANCIAL RESULTS AND DECLARES THIRD QUARTER 2026 DIVIDEND OF $0.48 PER SHARE DIVIDEND DECLARATIONS New York, NY — July 29, 2026 — Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) announced that its Board of Di

$OBDCMed

BDC Dividends Face a Reckoning As Fed Rate Cuts Squeeze Earnings

VanEck BDC Income ETF (BIZD) reported a July distribution of $0.24 per share, down from $0.48 in April. The article links the drop to lower Fed rates and spread compression affecting its underlying business development companies. It highlights dividend changes and coverage for ARCC, OBDC, BXSL, and MAIN, noting BIZD is down about 14% over a year.

$ARCCMedAI 8/10

ARES CAPITAL CORPORATION ANNOUNCES INAUGURAL $1 BILLION COMMERCIAL PAPER PROGRAM

Ares Capital Corporation (NASDAQ: ARCC) said it has launched an inaugural $1 billion commercial paper program to issue short-term, unsecured notes up to $1 billion outstanding at any time. The notes will rank pari passu with its other senior unsecured debt, with a $5.5 billion revolving credit facility as liquidity backstop. Net proceeds will be used for general corporate purposes.